258 related articles for article (PubMed ID: 7471099)
1. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.
Schmid FA; Otter GM; Stock CC
Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099
[TBL] [Abstract][Full Text] [Related]
2. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
Horton JK; Houghton PJ; Houghton JA
Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
[TBL] [Abstract][Full Text] [Related]
4. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
[TBL] [Abstract][Full Text] [Related]
5. Patterns of resistance and therapeutic synergism among alkylating agents.
Schabel FM; Trader MW; Laster WR; Wheeler GP; Witt MH
Antibiot Chemother (1971); 1978; 23():200-15. PubMed ID: 348078
[TBL] [Abstract][Full Text] [Related]
6. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
Sladek NE; Low JE; Landkamer GJ
Cancer Res; 1985 Feb; 45(2):625-9. PubMed ID: 3967238
[TBL] [Abstract][Full Text] [Related]
7. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
[TBL] [Abstract][Full Text] [Related]
8. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
Schmid FA; Otter GM; Chen CF
Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
[TBL] [Abstract][Full Text] [Related]
9. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
Goncharova SA; Minenkova EA; Fomina MM; Demidova NS
Eksp Onkol; 1984; 6(4):38-41. PubMed ID: 6499750
[TBL] [Abstract][Full Text] [Related]
11. Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
D'Incalci M; Torti L; Damia G; Erba E; Morasca L; Garattini S
Cancer Res; 1983 Dec; 43(12 Pt 1):5674-80. PubMed ID: 6357429
[TBL] [Abstract][Full Text] [Related]
12. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine].
Pukhal'skaia ECh; Platonova GN
Biull Eksp Biol Med; 1971 Oct; 72(10):82-5. PubMed ID: 5126158
[No Abstract] [Full Text] [Related]
13. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
Ahmad S; Okine L; Wood R; Aljian J; Vistica DT
J Cell Physiol; 1987 May; 131(2):240-6. PubMed ID: 2884224
[TBL] [Abstract][Full Text] [Related]
14. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
Goldenberg GJ
Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
Russo JE; Hilton J
Cancer Res; 1988 Jun; 48(11):2963-8. PubMed ID: 3365687
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine.
Sladek NE
J Pharmacol Exp Ther; 1977 Jan; 200(1):17-24. PubMed ID: 319221
[TBL] [Abstract][Full Text] [Related]
20. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
